166 related articles for article (PubMed ID: 37752421)
1. First case report of PLA2R-related monotypic (IgG-κ positive) membranous nephropathy concurrent with leukocyte chemotactic factor 2 amyloidosis.
Xu J; Wang X; Weng Q; Feng X; Pan X
BMC Nephrol; 2023 Sep; 24(1):283. PubMed ID: 37752421
[TBL] [Abstract][Full Text] [Related]
2. Renal leukocyte chemotactic factor 2 (ALECT2)-associated amyloidosis in Chinese patients.
Li DY; Liu D; Wang SX; Yu XJ; Cui Z; Zhou FD; Zhao MH
Amyloid; 2020 Jun; 27(2):134-141. PubMed ID: 32024381
[No Abstract] [Full Text] [Related]
3. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
[No Abstract] [Full Text] [Related]
4. A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
Arai H; Toda N; Kamimatsuse R; Nishioka K; Endo S; Akiyama S; Maruyama S; Matsubara T; Yokoi H; Yanagita M
Intern Med; 2018 Oct; 57(19):2873-2877. PubMed ID: 29709946
[TBL] [Abstract][Full Text] [Related]
5. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy.
Hoxha E; Thiele I; Zahner G; Panzer U; Harendza S; Stahl RA
J Am Soc Nephrol; 2014 Jun; 25(6):1357-66. PubMed ID: 24610926
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
[TBL] [Abstract][Full Text] [Related]
7. Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature.
Meyer N; Cooper W; Kirwan P; Garsia R; Dunkley S; Gracey DM
BMC Nephrol; 2021 Jul; 22(1):268. PubMed ID: 34294065
[TBL] [Abstract][Full Text] [Related]
8. PLA2R antibody levels and clinical outcome in patients with membranous nephropathy and non-nephrotic range proteinuria under treatment with inhibitors of the renin-angiotensin system.
Hoxha E; Harendza S; Pinnschmidt H; Panzer U; Stahl RA
PLoS One; 2014; 9(10):e110681. PubMed ID: 25313791
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
[TBL] [Abstract][Full Text] [Related]
10. Treatment resistant M-type phospholipase A2 receptor associated membranous nephropathy responds to obinutuzumab: a report of two cases.
Hudson R; Rawlings C; Mon SY; Jefferis J; John GT
BMC Nephrol; 2022 Apr; 23(1):134. PubMed ID: 35392837
[TBL] [Abstract][Full Text] [Related]
11. Membranous Nephropathy with Lambda Light Chain Restriction: A Rare Form with Serum Negative and Tissue Positive PLA2R Ab.
Isiktas Sayilar E; Kiremitci S; Ergun I; Ensari A
Nephron; 2022; 146(4):377-380. PubMed ID: 34937026
[TBL] [Abstract][Full Text] [Related]
12. PLA2R-positive membranous nephropathy in IgG4-related disease.
Ushio Y; Akihisa T; Karasawa K; Seki M; Kobayashi S; Miyabe Y; Kataoka H; Ito N; Taneda S; Akiyama S; Hebisawa A; Kawano M; Honda K; Hoshino J
BMC Nephrol; 2024 Feb; 25(1):66. PubMed ID: 38395839
[TBL] [Abstract][Full Text] [Related]
13. Membranous nephropathy with systemic light-chain amyloidosis of remission after rituximab therapy: A case report.
Zhang J; Wang X; Zou GM; Li JY; Li WG
World J Clin Cases; 2023 Aug; 11(23):5538-5546. PubMed ID: 37637680
[TBL] [Abstract][Full Text] [Related]
14. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.
Burbelo PD; Joshi M; Chaturvedi A; Little DJ; Thurlow JS; Waldman M; Olson SW
J Am Soc Nephrol; 2020 Jan; 31(1):208-217. PubMed ID: 31843984
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic membranous nephropathy with renal amyloidosis: A case report.
Wang Y; Wang X; Yu J; Wu S; Xu Z; Sun W
Front Med (Lausanne); 2022; 9():986065. PubMed ID: 36388894
[TBL] [Abstract][Full Text] [Related]
16. Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.
Yamazaki T; Takahashi H; Takeuchi K; Sakamoto E; Tominaga K; Sakurabayashi S; Abe T; Sano T; Wada Y; Kuwahara N; Shimizu A; Takeuchi Y
BMC Nephrol; 2023 Jul; 24(1):218. PubMed ID: 37488532
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
18. Membranous nephropathy: integrating basic science into improved clinical management.
Cattran DC; Brenchley PE
Kidney Int; 2017 Mar; 91(3):566-574. PubMed ID: 28065518
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
Ishiwatari A; Wakai S; Shirakawa H; Honda K
Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
[TBL] [Abstract][Full Text] [Related]
20. Anti-Phospholipase A2 Receptor (Anti-PLA2R) Antibody in Diagnosis and Treatment of Idiopathic Membranous Nephropathy: A Single-Center Observational Study in China.
Guo N; Cao Y; Dai H; Yuan L; Shi L; Zhang Y
Med Sci Monit; 2019 Dec; 25():9364-9368. PubMed ID: 31813930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]